These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9276769)

  • 1. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.
    Momiyama Y; Hartikainen J; Nagayoshi H; Albrecht P; Kautzner J; Saumarez RC; McKenna WJ; Camm AJ
    Jpn Circ J; 1997 Aug; 61(8):650-6. PubMed ID: 9276769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of microvolt T-wave alternans in the risk stratification of patients with hypertrophic cardiomyopathy.
    Fuchs T; Torjman A
    Isr Med Assoc J; 2009 Oct; 11(10):606-10. PubMed ID: 20077947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study.
    Saumarez RC; Slade AK; Grace AA; Sadoul N; Camm AJ; McKenna WJ
    Circulation; 1995 Jun; 91(11):2762-8. PubMed ID: 7758182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise recordings for the detection of T wave alternans. Promises and pitfalls.
    Albrecht P; Arnold J; Krishnamachari S; Cohen RJ
    J Electrocardiol; 1996; 29 Suppl():46-51. PubMed ID: 9238377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.
    Suszko A; Nayyar S; Labos C; Nanthakumar K; Pinter A; Crystal E; Chauhan VS
    J Am Heart Assoc; 2020 Sep; 9(17):e016461. PubMed ID: 32806990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the QT indices and the microvolt-level T wave alternans in cardiomyopathy.
    Kuroda N; Ohnishi Y; Adachi K; Yokoyama M
    Jpn Circ J; 2001 Nov; 65(11):974-8. PubMed ID: 11716250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms.
    Saumarez RC; Camm AJ; Panagos A; Gill JS; Stewart JT; de Belder MA; Simpson IA; McKenna WJ
    Circulation; 1992 Aug; 86(2):467-74. PubMed ID: 1638716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvolt T-wave alternans as a predictor of ventricular tachyarrhythmias: a prospective study using atrial pacing.
    Tanno K; Ryu S; Watanabe N; Minoura Y; Kawamura M; Asano T; Kobayashi Y; Katagiri T
    Circulation; 2004 Apr; 109(15):1854-8. PubMed ID: 15066948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and the prognostic value of microvolt T-wave alternans in patients with hypertrophic cardiomyopathy.
    Trzos E; Kasprzak JD; Krzemińska-Pakuła M; Rechciński T; Wierzbowska-Drabik K; Uznańska B; Śmiałowski A; Rudziński T; Kurpesa M
    Ann Noninvasive Electrocardiol; 2011 Jul; 16(3):276-86. PubMed ID: 21762256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy.
    Adachi K; Ohnishi Y; Shima T; Yamashiro K; Takei A; Tamura N; Yokoyama M
    J Am Coll Cardiol; 1999 Aug; 34(2):374-80. PubMed ID: 10440148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvolt QRS Alternans in Hypertrophic Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.
    Chakraborty P; Suszko AM; Viswanathan K; Sheikholeslami K; Spears D; Adler A; Woo A; Rakowski H; Chauhan VS
    J Am Heart Assoc; 2021 Dec; 10(23):e022036. PubMed ID: 34854315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical alternans and vulnerability to ventricular arrhythmias.
    Rosenbaum DS; Jackson LE; Smith JM; Garan H; Ruskin JN; Cohen RJ
    N Engl J Med; 1994 Jan; 330(4):235-41. PubMed ID: 8272084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.
    Swerdlow CD; Zhou X; Voroshilovsky O; Abeyratne A; Gillberg J
    Heart Rhythm; 2008 May; 5(5):670-6. PubMed ID: 18452868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced quantitative microvolt T-wave alternans in hypertrophic cardiomyopathy.
    de Oliveira Antunes M; Samesima N; Pereira Filho HG; Matsumoto AY; Verrier RL; Pastore CA; Arteaga-Fernández E; Mady C
    J Electrocardiol; 2017; 50(2):184-190. PubMed ID: 27916321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
    Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
    Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling.
    Narayan SM; Bayer JD; Lalani G; Trayanova NA
    J Am Coll Cardiol; 2008 Nov; 52(22):1782-92. PubMed ID: 19022157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.